Dr. Alexis Kalergis is a Full Professor at the Schools of Biological Sciences and Medicine of the Pontificia Universidad Católica de Chile and a Doctor on Microbiology and Immunology at the Albert Einstein College of Medicine in New York. He did two postdoctoral studies at Albert Einstein and the Rockefeller University. He has been Visiting Professor at the Albert Einstein College of Medicine, the University of Nantes, France and the University of Iowa in the USA. He has given more than 400 national and international conferences and published 330 scientific articles. It has trained many young scientists, several of whom hold academic positions in Chile and abroad.
He has received awards such as the Avonni National Innovation Award, the Andres Bello University Merit Award, the World Intellectual Property Organization Gold Medal, the Abdón Cifuentes Award that honors scientists with an impact on public policy, the Avonni Award for Innovative Career, and the Image Spirit Award from Chile, among others. He directs the Millennium Institute for Immunology and Immunotherapy, a center of excellence in international translational science. He has participated as an advisor in government and legislative commissions and as a member of the Scientific Advisory Council of the ICGEB (an United Nations Organization), of the Presidential Advisory Council for Science, Technology, Knowledge and Innovation of Chile, and the Advisory Council for the Directorate For Science, Technology And Innovation-Committee For Scientific And Technological Policy, OECD. He directs a scientific and clinical study project of one of the most advanced and safe COVID19 vaccines, which led to the preferential, priority and early supply of the necessary doses for the mass vaccination campaign against COVID-19 in Chile.